The rising cost of drugs is a cause for concern among various stakeholders in healthcare, some of who worry that staying on the current trajectory will “break the bank,” said panelists during a session at the ISPOR Annual Meeting.
Identifying simple practices that hospices can implement to contribute to fewer future patient hospitalizations can not only save on hospitalization costs, but also benefit patient quality of life.
What we're reading, June 27, 2016: Blue Cross and Blue Shield of Minnesota is leaving the individual market; out-of-pocket costs for hospital visits grew 37% in 5 years; and a growing number of millennials are becoming caregivers for loved ones.
Six former FDA commissioners participated in a discussion at the Aspen Ideas Festival on the challenges that the agency faces and whether it is well equipped to do its job.
At the Pharmacy Quality Alliance's Annual Meeting, Kate Goodrich, MD, of CMS, and a group of experts discussed the government's move toward value-based care and the use of quality measures.
More than 58% of healthcare payers’ businesses have already shifted to full value-based reimbursement models, a 10% increase since 2014.
Despite recommendations and the passage of legislation, there is little evidence that the quality of behavioral health has improved significantly over the last 10 years in the United States.
Prescription drug spending between 2014 and 2015 increased at a much higher rate among health exchange plans compared with commercial plans, Medicare, and Medicaid plans. Express Scripts highlighted 3 select trends that are having the biggest impact on plans.
Diabetes Compendium
Oncology Compendium
Reimbursement Compendium
Know Your News
HF Compendium